Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
57,260,089
-
Share change
-
+883,905
-
Total reported value
-
$8,932,716,610
-
Put/Call ratio
-
201%
-
Price per share
-
$156.01
-
Number of holders
-
448
-
Value change
-
+$138,065,500
-
Number of buys
-
193
-
Number of sells
-
199
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2022
As of 30 Jun 2022,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
448 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,260,089 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, LSV ASSET MANAGEMENT, FMR LLC, Polaris Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and SAMLYN CAPITAL, LLC.
This page lists
448
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.